NL-OMON27800
Recruiting
Not Applicable
Pancreatic Locally advanced Irresectable Cancer Ablation in the Netherlands
Olympus Medical Systems: CelonPowerSystem; CelonProSurge probes0 sites228 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pancreatic cancer
- Sponsor
- Olympus Medical Systems: CelonPowerSystem; CelonProSurge probes
- Enrollment
- 228
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
not yet
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Histologically or cytologically confirmed adenocarcinoma of the pancreas
- •2\.Locally irresectable tumor (according to the Dutch Pancreatic Cancer Group criteria; www.dpcg.nl)
Exclusion Criteria
- •1\.WHO performance status ≥ 3
- •2\.Distant metastases on abdominal or thoracic CT scan\*
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Pancreatic Locally advanced Irresectable Cancer AblatioN (PELICAN trial)Locally advanced pancreatic cancernon-resectabel pancreatic tumor10017998NL-OMON56404Amsterdam UMC174
Active, not recruiting
Phase 1
ocally Advanced Pancreatic Cancer: Phase II study of cetuximab and 3-D conformal image-guided radiotherapy (PACER Study) - PACER StudyEUCTR2006-001742-13-GBChristie Hospital NHS Trust44
Active, not recruiting
Not Applicable
Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRIPancreas CancerAdenocarcinomaNCT05511116Fondation Hôpital Saint-Joseph48
Completed
Phase 1
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP TrialHistologically or Cytologically Confirmed Pancreatic CaUnresectable or Borderline Resectable Pancreatic CaNCT01294358National Cancer Institute (NCI)7
Unknown
Not Applicable
VENous Invasion in PANcreatic CancerPancreatic cancerNL-OMON27194MC500